Jefferies Adjusts Fortis Healthcare's Price Target to INR725 From INR575, Keeps at Buy
National Bank Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.08
Fortis Maintained at Sector Perform at National Bank Following Q3 Results; Price Target Raised to C$63.00
CIBC Maintains Fortis(FTS.US) With Hold Rating, Cuts Target Price to $45.08
Wells Fargo Maintains Fortis(FTS.US) With Hold Rating, Cuts Target Price to $45.08
Wells Fargo Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.38
RBC Capital Maintains Fortis(FTS.US) With Hold Rating, Maintains Target Price $46.82
Wells Fargo Reaffirms Their Hold Rating on Fortis (FTS)
Fortis's Sell Rating: Regulatory Challenges and Below-Average EPS Growth Overshadow Positive Q3'24 Earnings
Raymond James Downgrades Fortis(FTS.US) to Hold Rating, Raises Target Price to $43.94
Fortis Downgraded to Market Perform From Outperform at Raymond James
Fortis Maintained at Sector Perform at National Bank Financial Following Q3 Results; Price Target Kept at C$62.00
RBC Capital Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $46.79
J.P. Morgan Maintains Fortis(FTS.US) With Sell Rating, Raises Target Price to $43.44
CIBC Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.57
RBC Capital Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $47.96
Fortis Inc. Is Maintained at Sector Perform by RBC Capital
RBC Capital Maintains Fortis(FTS.US) With Hold Rating, Maintains Target Price $45.88
Fortis Healthcare Target Price Raised to INR588 From INR485 by BNP Paribas Securities India >532843.BY
BMO Capital Maintains Fortis(FTS.US) With Hold Rating, Raises Target Price to $45.97